Recently KL-6 serum concentrations were demonstrated to be significantly higher in patients with severe COVID-19 vs. non-severe COVID-19 and healthy controls, demonstrating potential prognostic value (d’Alessandro et al., 2020). This evidence concerns the gene MUC1 and COVID-19.